- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Congress Must Act for Cannabis Patients! Pass Medical Cannabis Legislation NOW! Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2021 State of the States Medical Cannabis Access for Pain Treatment Cannabis and Cannabis Resin- Critical Review Preparation Document Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
ARCHIVE Published on: 2008-06-01
In October, 2005, California's Board of Equalization (BoE), which deals with state taxation issues, voted to tax monetary transactions involving medical marijuana. ASA is against the taxation of medical marijuana for two main reasons: a) the proposed sales tax is regressive and has the potential to significantly increase cost for medicine, and b) the requirement of providers to report receipts and other information would violate their constitutional right against self-incrimination. On August 10, 2005, ASA attended a public hearing with the BoE, and submitted a position paper on the matter.
On October 25, 2005, the Business Taxes Committee met to review its policy on sales tax of medical marijuana. In its review, the Committee and Board (as the Committee is made up of the entire Board) considered ASA’s position paper and its own BoE issue paper. Ultimately, the BoE decided at that October 25, 2005 meeting to amend its policy to require that all transactions of medical marijuana be subject to sales tax and to require all providers apply for sellers permits. But, because of ASA’s intervention, the BoE adopted a policy that allows providers to omit details of the product being sold in order to avoid self-incrimination. In February 2007, the BoE issued a notice to many of the dispensaries throughout California, explaining their obligation to apply for sellers permits.
In early 2008, ASA and other advocacy groups conducted a study to determine the extent of sales tax revenue collected from the sale of medical marijuana at dispensaries across the state. As a result of that study, it was estimated that in 2007 patients and providers in California contributed more than $100 million in annual sales tax revenue to the state general budget.
- ASA's position paper against the taxation of medical marijuana sales (filed 8/10/05)
- BoE issue paper (issued 10/14/05)
- BoE notice to all California dispensing collectives (issued 2/07)
- ASA fact sheet on sales tax (issued 2008)